News

News and Press Releases
Research | About the CF Foundation | Our Research Approach Cystic Fibrosis Foundation Launches $500 Million Path to a Cure

Nonprofit issues challenge to accelerate treatments for every person with CF

| 5 min read
Research | CFTR Modulators | Drug Pipeline Cystic Fibrosis Foundation statement on FDA approval of TRIKAFTA, the first triple combination therapy for the most common CF mutation

This medicine represents the single greatest therapeutic advancement in the history of CF, offering a treatment for the underlying cause of the disease that could eventually benefit more than 90 percent of people with CF.  

| 3 min read
About the CF Foundation Preston W. Campbell, MD, President and CEO to Retire; Michael P. Boyle, MD, Appointed as Successor

Preston W. Campbell, III, President and CEO to retire; Michael P. Boyle, MD, appointed as successor effective January 2020.

| 4 min read